SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-054003
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:45
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2412855d1_10ka.htm   iXBRL 10-K/A 632043
2 EXHIBIT 31.3 tm2412855d1_ex31-3.htm EX-31.3 3877
3 EXHIBIT 31.4 tm2412855d1_ex31-4.htm EX-31.4 3885
  Complete submission text file 0001104659-24-054003.txt   938505

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pgen-20231231.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20231231_lab.xml EX-101.LAB 36884
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20231231_pre.xml EX-101.PRE 24146
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2412855d1_10ka_htm.xml XML 6281
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36042 | Film No.: 24890609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)